U. Sorro

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneuropathy And Treatment with Hizentra study

D. Yarnitsky, M. Valis, H. Hartung, 2019, Journal of the peripheral nervous system : JPNS.

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

G. L. Masson, D. Yarnitsky, S. Muley, 2018, The Lancet Neurology.

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

G. L. Masson, D. Yarnitsky, M. Valis, 2019, Journal of the peripheral nervous system : JPNS.

Cognitive dysfunction during anti-NMDA-receptor encephalitis is present in early phase of the disease

T. Talvik, K. Gross-Paju, L. Vahter, 2014, Oxford medical case reports.